Riskpilot← Back to searchSign inGet full accessBAKKEN HELSE AS
ASActiveOrg 920192785Bjergvegen 128, 6657 RindalTraditional, complementary and alternative medicine activities · NACE 8696Est. 20187 employees
Revenue 2024
NOK 4,4M
+2% vs 2023
EBITDA margin
2.3%
+34% vs 2023
Equity ratio
10.2%
Financial strength
Net profit 2024
NOK 71K
+121% vs 2023
| Revenue | NOK 4,4M | +2% |
| EBITDA | NOK 101K | +34% |
| Net profit | NOK 71K | +121% |
| Total assets | NOK 376K | +21% |
| Equity | NOK 38K | +218% |
| Employees | 7 | — |
Legal name
BAKKEN HELSE AS
Org number
920192785
Legal form
Aksjeselskap
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
8. januar 2018
Share capital
NOK 30 000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Tilby helsetjenester i form av behandling(kiropraktor/akupunktur/fysioterapi), trening og andre helsefremmendetiltak. Videre å tilby andre produkter/tjenester som nat sammen med dette, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
Bjergvegen 128, 6657 Rindal
Phone
+4745785501
Email
post@bakkenhelse.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 653 | 3 871 | 3 530 | 4 317 | 4 407 |
| Staff expenses | −577 | −643 | −648 | −656 | −703 |
| EBITDA | 36 | 100 | −86 | 75 | 101 |
| Depreciation & amort. | −39 | −54 | −55 | −38 | −27 |
| EBIT | −3 | 46 | −141 | 37 | 73 |
| Net financials | −10 | −7 | −6 | −5 | −2 |
| Profit before tax | −13 | 39 | −147 | 32 | 71 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −13 | 39 | −147 | 32 | 71 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 329 | 413 | 348 | 310 | 376 |
| Equity | 42 | 81 | −66 | −33 | 38 |
| Long-term debt | 178 | 140 | 100 | 62 | 13 |
| Short-term debt | 109 | 192 | 314 | 281 | 325 |
| Total debt | 287 | 332 | 414 | 342 | 338 |
EBITDA margin
2.3%
This company
15.8%
Market median
-85% vs market
20202024
Equity ratio
10.2%
This company
38.2%
Market median
-73% vs market
20202024
Return on equity
184.5%
This company
18.4%
Market median
+903% vs market
20202024
Net profit margin
1.6%
This company
8.1%
Market median
-80% vs market
20202024
Asset turnover
11.72×
This company
1.12×
Market median
+946% vs market
20202024
Debt / equity
8.78×
This company
0.62×
Market median
-1316% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EB Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2018 | |
| Board of Directors | 2018 | |
| Board of Directors | 2018 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BAKKEN HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Bakken | Chief Executive Officer | 0 companies |
| Nils Bakken | Chairman | 0 companies |
| Elmer Talgø | Board of Directors | 0 companies |
| Hedvig Bakken | Board of Directors | 0 companies |